Among the people most at risk for hospitalization and death from COVID-19 are people with pre-existing cardiovascular issues. To avoid potentially serious consequences from SARS-CoV-2 infections, doctors may choose to prescribe patients Pfizers Paxlovid.<\/p>\n
It has become clear, however, that Paxlovid may adversely interact with a range of common heart medications patients may already be taking.<\/p>\n
A new study reviews known interactions between Paxlovid and some heart disease medications and offers ways to avoid unwanted outcomes.<\/p>\n
The study is published in the Journal of the American College of Cardiology.<\/p>\n
Dr. Scott Roberts, assistant professor and associate medical director of infection prevention at Yale Medicine in New Haven, Connecticut, who was not involved in the study, weighed in on the findings.<\/p>\n
I imagine patients with cardiovascular conditions will have a harder time taking Paxlovid safely than those with other types of medical problems. The challenge with Paxlovid use in those with cardiovascular disease is the abundance of drug-drug interactions between many medications taken for cardiovascular conditions (such as blood thinners, anti-arrhythmics) and Paxlovid, which can lead to dangerous increases in some of these drugs levels, he told Medical News Today:<\/p>\n
Senior author of the study, Dr. Sarju Ganatra, a cardiologist at Beth Israel Lahey Health in Burlington, Massachusets, told MNT that even considering the care that must be taken to avoid conflicts, We believe it [Paxlovid] is a good drug and can be very helpful.<\/p>\n
We should not be deterred from considering Paxlovid as a potential treatment for COVID-19. However, co-administration of Paxlovid with medications commonly used to manage cardiovascular conditions can potentially cause significant drug-drug interactions and may lead to severe adverse effects. Dr. Sarju Ganatra<\/p>\n
It is crucial to be aware of such interactions and make appropriate adjustments in the medication regimen to avoid any harm, said Dr. Ganatra.<\/p>\n
Paxlovid was authorized for emergency use against COVID-19 by the Federal Food and Drug Administration at the end of last year and was reauthorized in September 2022.<\/p>\n
The issue of drug interactions is unrelated to Paxlovid rebound.<\/p>\n
Dr. Ganatra listed the types of drugs with which negative interactions may occur when taken alongside Paxlovid:<\/p>\n
The study includes a detailed listing of specific interactions, as well as alternative treatments to avoid conflicts with Paxlovid.<\/p>\n
The researchers have also proposed a multi-level decision algorithm that can help clinicians determine whether Paxlovid is indicated for individual patients based on the cardiovascular medications they are already taking.<\/p>\n
Paxlovid may also conflict with some medications prescribed for other conditions.<\/p>\n
Many medications can interact with Paxlovid, said Dr. Ganatra, [The] FDA has issued a list very recently, although without much details.<\/p>\n
Dr. Roberts mentioned an additional interaction issue with Paxlovid:<\/p>\n
Another major one is anti-rejection medications for those with organ transplants.<\/p>\n
The levels can go dangerously high when given with Paxlovid unless the dosages are adjusted. I always advise discussing with a pharmacist how to modify the doses of medications a patient is taking when starting Paxlovid, he explained.<\/p>\n
The Nirmatrelvir-ritonavir combination known as Paxlovid is used to treat symptomatic, non-hospitalized patients with coronavirus disease-2019 (COVID-19) who are at high risk of progression to severe disease, explained Dr. Ganatra.<\/p>\n
Patients with cardiovascular risk factors and cardiovascular disease, he noted, are at a high risk of developing adverse events from COVID-19 and as a result have a higher likelihood of receiving Paxlovid. So, Paxlovid and heart-medication interactions are very important to understand and avoid.<\/p>\n
Even so, said Dr. Ganatra, Paxlovid should be considered when indicated, keeping these interactions in mind and making adjustments in the drug regimen to avoid them.<\/p>\n
Dr. Ganatra noted his research indicates Paxlovid may be even more valuable than first believed:<\/p>\n
Paxlovid was originally shown to be beneficial for unvaccinated patients. However, we did a follow-up real-world study and demonstrated that it is beneficial for high-risk vaccinated patients as well, such as those with heart disease.<\/p>\n
Dr. Ganatra said that he hopes his review study will be helpful for clinicians to understand such interactions and also to make point-of-care decisions.<\/p>\n
We believe, its important for providers and hospitals to create system-level interventions such as building in these interactions in the EMR [electronic medical records] system to alert the clinicians\/prescribers to ensure patients get the right treatment, and we can avoid potentially harmful drug-drug interactions. Dr. Sarju Ganatra<\/p>\n
<\/p>\n
Originally posted here:<\/p>\n
Can you take Paxlovid and heart disease medications at the same time? - Medical News Today<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Among the people most at risk for hospitalization and death from COVID-19 are people with pre-existing cardiovascular issues. To avoid potentially serious consequences from SARS-CoV-2 infections, doctors may choose to prescribe patients Pfizers Paxlovid. It has become clear, however, that Paxlovid may adversely interact with a range of common heart medications patients may already be taking. Continue reading